The United States Preventive Services Task Force (USPSTF) recently released recommendations against the use of hormone replacement therapy in menopausal women for the prevention of chronic disease. The May recommendation, released to help guide clinicians and their patients, was an update to previously released recommendations on the use of hormone replacement therapy (HRT).
New recommendations for HRT create additional patient confusion
It is hard to imagine that June—and with it, the annual ASMBS (American Society of Metabolic & Bariatric Surgery) conference—is upon us again. The conference is taking place during an exciting time for the bariatric industry, which is anxiously awaiting a new set of bariatric Center of Excellence (CoE) recommendations next year. The last few months alone have seen a number of developments in bariatrics—most notably the merger of the ASMBS and ACS (American College of Surgeons) bariatric surgery accrediting bodies. Suffice to say, our team is eager for a chance to hear first-hand from clinicians and other national champions at the meeting this week.
Here, we have outlined what we are most looking forward to.
Preview to ASMBS 2012 - key topics to watch for in bariatric surgery